Psychosocial risk factors for increased emergency hospital utilization by sickle cell disease patients: a systematic review protocol.
Journal
JBI evidence synthesis
ISSN: 2689-8381
Titre abrégé: JBI Evid Synth
Pays: United States
ID NLM: 101764819
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
entrez:
16
3
2021
pubmed:
17
3
2021
medline:
22
5
2021
Statut:
ppublish
Résumé
To assess psychosocial risk factors for increased emergency hospital utilization by sickle cell patients. Emergency hospital utilization by sickle cell disease patients is high but heterogeneous between patients and in a given patient over time. Psychosocial factors affect emergency hospital utilization and are a possible target to improve the management of sickle cell disease. This review will include all original quantitative studies evaluating the impact of psychosocial risk factors on emergency hospital utilization by sickle cell disease patients. There will be no language restriction. PubMed, Embase, CINAHL, PubPsych, LiSSa, and Web of Science will be searched using a peer-reviewed search strategy. Study selection and extraction of data will be performed independently by two authors. Discrepancies will be solved by consensus or, if needed, by a third author. The authors will assess study quality, as well as perform a narrative synthesis of included studies, and where possible, meta-analyses with evaluation of heterogeneity and publication bias. PROSPERO CRD42019140435.
Identifiants
pubmed: 33725714
doi: 10.11124/JBIES-20-00041
pii: 02174543-202103000-00014
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
682-688Informations de copyright
Copyright © 2021 JBI.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med 2013; 10 (7):e1001484.
Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med 2017; 376 (16):1561–1573.
Lanzkron S, Carroll CP, Haywood C. The burden of emergency department use for sickle cell disease: an analysis of the national emergency department sample database. Am J Hematol 2010; 85 (10):797–799.
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008; 148 (2):94–101.
Blank FSJ, Li H, Henneman PL, Smithline HA, Santoro JS, Provost D, et al. A Descriptive study of heavy emergency department users at an academic emergency department reveals heavy ED users have better access to care than average users. J Emerg Nurs 2005; 31 (2):139–144.
Maitra P, Caughey M, Robinson L, Desai PC, Jones S, Nouraie M, et al. Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe. Haematologica 2017; 102 (4):626–636.
Houston-Yu P, Rana SR, Beyer B, Castro O. Frequent and prolonged hospitalizations: a risk factor for early mortality in sickle cell disease patients. Am J Hematol 2003; 72 (3):201–203.
Pereira SA dos S, Brener S, Cardoso CS, Proietti AB de FC. Sickle cell disease: quality of life in patients with hemoglobin SS and SC disorders. Rev Bras Hematol E Hemoter 2013; 35 (5):325–331.
Jackson JL, Lemanek KL, Clough-Paabo E, Rhodes M. Predictors of health-related quality of life over time among adolescents and young adults with sickle cell disease. J Clin Psychol Med Settings 2014; 21 (4):313–319.
Glassberg JA, Tanabe P, Chow A, Harper K, Haywood C, DeBaun MR, et al. Emergency provider analgesic practices and attitudes toward patients with sickle cell disease. Ann Emerg Med 2013; 62 (4):293–302.e10.
Haywood C, Diener-West M, Strouse J, Carroll CP, Bediako S, Lanzkron S, et al. Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease. J Pain Symptom Manage 2014; 48 (5):934–943.
Pizzo E, Laverty AA, Phekoo KJ, AlJuburi G, Green SA, Bell D, et al. A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11. J Public Health 2015; 37 (3):529–539.
Lanzkron S, Haywood C, Segal JB, Dover GJ. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol 2006; 81 (12):927–932.
Carroll CP, Haywood C, Lanzkron S. Prediction of onset and course of high hospital utilization in sickle cell disease. J Hosp Med 2011; 6 (5):248–255.
Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med 1991; 325 (1):11–16.
Linton E, Langer AL, Glassberg J. Hospital admissions, mortality and comorbidities among new york state sickle cell patients, 2005-2013. J Natl Med Assoc 2018; 110 (2):149–156.
Gellman MD, Turner JR, editors. Encyclopedia of behavioral medicine [internet]. New York, NY: Springer New York; 2013 [cited 2020 Apr 30]. Available from: http://link.springer.com/10.1007/978-1-4419-1005-9.
Benenson I, Jadotte Y, Echevarria M. Factors influencing utilization of hospital services by adult sickle cell disease patients: a systematic review. JBI Database Syst Rev Implement Rep 2017; 15 (3):765–808.
Anie KA. Coping and health service utilisation in a UK study of paediatric sickle cell pain. Arch Dis Child 2002; 86 (5):325–329.
AlJuburi G, Laverty AA, Green SA, Phekoo KJ, Bell D, Majeed A. Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: observational study. J Public Health 2013; 35 (4):510–517.
Carroll PC, Haywood C, Hoot MR, Lanzkron S. A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients. Clin J Pain 2013; 29 (4):317–323.
Jonassaint CR, Jones VL, Leong S, Frierson GM. A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. Br J Haematol 2016; 174 (1):136–147.
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidemiol 2016; 75:40–46.
Moola S, Munn Z, Tufarnu C, Aromataris E, Sears K, Sfetcu R. Aromataris E, Munn Z, et al. Chapter 7: Systematic reviews of etiology and risk. JBI, JBI Reviewer's Manual. Adelaide:2017.
Moher D, Liberati A, Tetzlaff J, Altman DG. the PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009; 6:6.
Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med 2013; 158 (4):280.
Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, et al. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ 2019; k4597.
Murad MH, Wang Z, Chu H, Lin L. When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation. BMJ 2019; k4817.
Tufanaru C, Munn Z, Stephenson M, Aromataris E. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc 2015; 13 (3):196–207.
Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ 2015; 350:h870–h1870.